Marks A - Search Results

1

RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.

Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, Hanna W, Narod S, McCready DR, Seth A, Marks A. Kahn HJ, et al. Among authors: marks a. Breast Cancer Res Treat. 2000 Mar;60(2):143-51. doi: 10.1023/a:1006350913243. Breast Cancer Res Treat. 2000. PMID: 10845277

2

Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage.

Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A. Kahn HJ, et al. Among authors: marks a. Breast Cancer Res Treat. 2004 Aug;86(3):237-47. doi: 10.1023/B:BREA.0000036897.92513.72. Breast Cancer Res Treat. 2004. PMID: 15567940

3

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.

Wong NS, Kahn HJ, Zhang L, Oldfield S, Yang LY, Marks A, Trudeau ME. Wong NS, et al. Among authors: marks a. Breast Cancer Res Treat. 2006 Sep;99(1):63-9. doi: 10.1007/s10549-006-9181-4. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541316

4

Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.

Kahn HJ, Hanna WM, Chapman JA, Trudeau ME, Lickley HL, Mobbs BG, Murray D, Pritchard KI, Sawka CA, McCready DR, Marks A. Kahn HJ, et al. Among authors: marks a. Breast J. 2006 Jul-Aug;12(4):294-301. doi: 10.1111/j.1075-122X.2006.00267.x. Breast J. 2006. PMID: 16848838

5

Defining a test for HER-2/neu evaluation in breast cancer in the diagnostic setting.

Hanna WM, Kahn HJ, Pienkowska M, Blondal J, Seth A, Marks A. Hanna WM, et al. Among authors: marks a. Mod Pathol. 2001 Jul;14(7):677-85. doi: 10.1038/modpathol.3880372. Mod Pathol. 2001. PMID: 11455000

6

Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers.

Kollara A, Kahn HJ, Marks A, Brown TJ. Kollara A, et al. Among authors: marks a. Breast Cancer Res Treat. 2001 Jun;67(3):245-53. doi: 10.1023/a:1017938608460. Breast Cancer Res Treat. 2001. PMID: 11561770

7

Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.

Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN. Arnaout-Alkarain A, et al. Among authors: marks an. Mod Pathol. 2007 Feb;20(2):183-91. doi: 10.1038/modpathol.3800728. Epub 2007 Jan 5. Mod Pathol. 2007. PMID: 17206106 Free article.

8

A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors.

Kahn HJ, Marks A. Kahn HJ, et al. Among authors: marks a. Lab Invest. 2002 Sep;82(9):1255-7. doi: 10.1097/01.lab.0000028824.03032.ab. Lab Invest. 2002. PMID: 12218087 Free article. No abstract available.

9

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L. Niakosari F, et al. Among authors: marks a. Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462. Arch Dermatol. 2008. PMID: 18427039

10

Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.

Kahn HJ, Bailey D, Marks A. Kahn HJ, et al. Among authors: marks a. Mod Pathol. 2002 Apr;15(4):434-40. doi: 10.1038/modpathol.3880543. Mod Pathol. 2002. PMID: 11950918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

887 results

Search Page